Media Coverage

A Harris Poll conducted by Quest Diagnostics suggests that more than 65% of US physicians believe the Alzheimer disease field is on the cusp of a breakthrough, with more than 80% noting that earlier evaluation with blood testing may help improve therapeutic approaches.

"2022 Health at Work" report from Quest Diagnostics reveals the attitudes and expectations of HR executive decision makers (HREs) and employees about the changing world of work, employee health and COVID-19, and what it takes to compete for today's scarcest resource–people.

A majority of physicians believe medicine is on the verge of groundbreaking new treatments for Alzheimer's disease, according to research from Quest Diagnostics.

While value-based care contracts have long played a role in the lab industry, recent comments by Quest Diagnostics executives suggest that such arrangements are growing more prominent and more profitable.

As millions of U.S. employees voluntarily resign and employers desperately scramble to find workers, a new survey suggests employee health strategy might be critical not only to keeping employees well but also keeping them at work. The “2022 Health at Work” report, released by Quest Diagnostics, addresses such hot-button topics as the changing world of work, employee health, and COVID-19.

Digital pathology is here to stay – and we need to embrace it. About the Author: Martin Potash is Managing Director of AmeriPath Denver, Quest Diagnostics, Colorado, USA.

Testing giant Quest Diagnostics is diving into the market for blood tests that aid in the early detection of Alzheimer’s disease. The disease afflicts millions of people around the world. But early detection typically relies on costly methods such as brain imaging and cerebrospinal fluid taps. Blood tests like the one developed by Quest promise to make detection easier, less costly and more accessible.

Testicular cancer is highly treatable when diagnosed before reaching advanced stages, and like most cancers, early detection is key in helping to combat it. It’s recommended that males perform routine self-testicular exams, especially between the ages of 18 and 40, and pay close attention to any new findings such as changes of size of the testicle, differences with new firm areas or bumps that have not been there before. "Whether you’re regularly going to the doctor’s office or not, anyone with testicles should administer an at-home check every month or so,” said Dr. Jeffrey Dlott, the medical director of QuestDirect.

Returning guest, Dr. Jeffrey Dlott, Medical Director at QuestDirect, discusses the new “Future of Personalized Healthcare Insights Study 2022” that was conducted by Leaf Group in collaboration with QuestDirect and Well+Good. The study provides a deeper understanding of perceptions and preferences around telehealth, health data usage, and tech adoption, as well as ways to improve a patient’s healthcare journey.

Some in the clinical lab space are concerned that the US Centers for Disease Control and Prevention's recently updated draft guidelines for prescribing opioids downplays the role of toxicology testing in patient monitoring and management. Jeff Gudin, an anesthesiologist and pain management specialist at the University of Miami, Miller School of Medicine as well as senior medical advisor to Quest Diagnostics' drug monitoring and toxicology franchise, said that toxicology testing is essential to physician's understanding of what other drugs might be in a patient's system and whether or not they are using their medication as prescribed.